arrow
P

Paola Ulivi

catholic university of the sacred heart
H指数:39
被引数:5,301

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non-small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial-HYPERBOLIC Study

PD-L1 ≥ 50% 非小细胞肺癌中cemiplimab单药或联合短程化疗的超进展:一项生物标志物指导的多中心国际II期试验—HYPERBOLIC研究

2026-09-010
PRE
Early-Phase Activation of Epithelial–Mesenchymal Transition in Lung Cancer Cells Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

表皮生长因子受体酪氨酸激酶抑制剂处理的肺癌细胞中上皮-间质转化的早期激活

2026-08-120
OA
Investigating biochemical markers of Acupuncture's effectiveness in managing climacteric syndrome in breast cancer patients: the FLAIR study

探究针灸在管理乳腺癌患者围绝经期综合征有效性方面的生化标志物:FLAIR研究

2025-11-200
PRE
Genomic and Transcriptomic Profiles in Smokers and Never-Smokers Lung Squamous Cell Carcinoma Patients

吸烟者和从未吸烟者肺鳞癌患者的基因组与转录组特征

2025-06-280
OA
Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants

探索三阴性乳腺癌患者中癌症易感基因的启动子区域,发现存在罕见的胚系变异。

2025-05-080
OA
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy
2025-02-100
OAAI
Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival
2025-02-010
OAAI
Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profiling

在转移性乳腺癌中整合机器学习预测的循环肿瘤细胞 (ctc) 和循环肿瘤DNA (ctDNA): 内分泌耐药分析的原理研究证明

2025-01-010
PRE
Detection of circulating tumor DNA and chromosome 3p25.3 gain in relapsed/refractory germ cell tumors and impact of salvage high-dose chemotherapy: Results from the Italian Germ Cell Cancer Group 04 study

循环肿瘤DNA和3p25.3染色体增益在复发/难治性生殖细胞瘤中的检测及挽救性大剂量化疗的影响:意大利生殖细胞癌研究组04研究的结果

2024-09-010
PRE
Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING study
2024-08-220
OAAI